Location: INTERPHEX Innovation Stage 2, Exhibit Hall The FDA is working on a Guidance detailing its suggested uses for Quality Agreements, the written agreements that define responsibilities for CMOs and.
April 1
Location: INTERPHEX Innovation Stage 2, Exhibit Hall The FDA is working on a Guidance detailing its suggested uses for Quality Agreements, the written agreements that define responsibilities for CMOs and.
Location: INTERPHEX Innovation Stage 2, Exhibit Hall In this PBOA-sponsored session, moderator Jim Miller (Founder, President of PharmSource) talks to a panel of top executives in the CMO/CDMO space. With.
Presenter: Michiel Ultee • Principal Consultant, Ulteemit BioConsulting, LLC Location: INTERPHEX Innovation Stage 2, Exhibit Hall The Biologic IND (Investigational New Drug) application is a critical, early milestone in evaluating.
In which we cover the PDA Annual Meeting and DCAT Week, even though they overlap and are 3 time zones apart.
The PBOA will offer a broad array of resources to its members, affiliates and the industry at large.
Resources
Events Calendar
Blog